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Abstract
Purpose
The purpose of the study was to evaluate the construct validity and reliability of the Korean
version of the revised Piper Fatigue Scale (PFS) in Koreans with chronic hepatitis B.
Methods
A total of 146 chronic hepatitis B patients completed the Korean version of the revised PFS.
A descriptive analysis was performed to determine the subjects’ demographic characteris-
tics; the construct validity was examined using exploratory factor analysis; and internal con-
sistency reliability of the scale was estimated for the meaningful total scale and factors.
Results
The factor analysis supported the original four-factor structure based on Kaiser Criterion
and Minimum Average Partial (MAP): Behavioral/Severity, Affective meaning, Sensory, &
Cognitive/Mood. In the 22 items in the original instrument, patient/impatient, relaxed/tense,
and exhilarated/depressed were re-identified from the cognitive/mood subscale and sensory
subscale. The Cronbach’s alpha of the 22-item Korean version of the revised PFS was 0.96
for the total scale, and the range of Cronbach’s alpha for subscales was 0.90 to 0.93.
Conclusions
The results of the study revealed that the 22-item Korean version of the revised PFS is valid
and reliable in Koreans with chronic hepatitis B. Further studies ascertaining the psychomet-
ric properties of the revised PFS need to be performed in Korean patients.
Introduction
Hepatitis B virus (HBV) is the most common chronic viral infection [1]. Two billion people
have been infected by HBV, and more than 240 million people are living with chronic hepatitis
B [2]. The prevalence of hepatitis B has decreased, but 4% of adults over 30 years old or older
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are infected with HBV in Korea [3]. Up to 40% of HBV-infected patients develop liver cirrho-
sis, liver failure, or hepatocellular carcinoma [4], and it is known that about 15% to 25% of
people with chronic HBV infection die from liver cirrhosis or hepatocellular carcinoma [5].
Patients with HBV experience various types of physical, psychological, and social problems,
which decrease their quality of life [6, 7]. HBV causes high social and economic burden
because most people with HBV are of working age.
Fatigue is a major symptom in people with hepatitis [7, 8]. To understand the characteris-
tics of fatigue such as severity it may be important to provide tailored interventions and to
improve health outcomes in this population. However, little is known about fatigue among
patients with HBV, and there is no suitable instrument to measure the nature of fatigue in
these patients.
The revised Piper Fatigue Scale (PFS) is one of the popular instruments to assess perceived
fatigue of patients with chronic disease such as cancer. This instrument consists of 22 items
and four subscales to assess multidimensional fatigue [9]. The scale was originally developed
with 42 items in 1989, and then it was revised to 22 items based on a study of women with
breast cancer in 1998 [9, 10]. The final version of the PFS consists of four dimensions of sub-
jective fatigue, and the subscales are behavioral/severity (six items), affective meaning (five
items), sensory (five items), and cognitive/mood (six items). 1) The behavioral/severity sub-
scale consists of items related to the impact and distress on activities of daily living, 2) the affec-
tive meaning subscale consists of items related to the emotional attributes of fatigue, 3) the
sensory subscale consists of items related to physical symptoms of fatigue, 4) and the cogni-
tive/mood subscale consists of items related to mental and mood status [9].
Although it was developed for patients with cancer, the PFS has been globally used to mea-
sure fatigue in diverse disease populations [11–13]. In Korea, the PFS has been used for mea-
suring the fatigue level of cancer patients such as breast cancer and gynecologic cancer. A
previous study reported that the fatigue level of Korean women cancer patients undergoing
chemotherapy was moderate, with the sensory subscale being the highest, followed by behav-
ioral/severity and then affective meaning [14]. In Korean breast cancer patients, the total
fatigue score was moderate, while the highest subscale was behavioral/severity [15], represent-
ing a different patterns of subscales compared to that in the first study. Therefore, the patterns
of fatigue can vary depending on disease type. However, the PFS scale has never been used to
assess or measure the fatigue and psychometric features of patients with HBV; however, this
assessment is required prior to application of the PFS in research and clinical practice. There-
fore, the purpose of the study was to evaluate the construct validity and reliability of the
Korean version of the revised Piper Fatigue Scale (PFS) in Koreans with chronic hepatitis B.
Materials and methods
Research design
This study is a methodological research design to evaluate the validity and reliability of the
Korean version of the revised PFS for patients with HBV.
Participants and data collection
The participants were recruited from March to May in 2011 at the outpatient clinic of a univer-
sity medical center in Seoul, Korea. Inclusion criteria were as follows: 1) patients who were
diagnosed with HBV over three months after detected HBsAg over six months, 2) age greater
than 20 years, 3) patients who had no liver cirrhosis or hepatocellular carcinoma, 4) patients
who had other infectious diseases or immune diseases, and 5) patients who were able to under-
stand and sign the informed consent form.
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The required sample size for evaluating the validity and reliability of an instrument is five
times the number of items [16]. Based on this, 146 HBV patients participated in the study
using the revised 22-item PFS. Thus, it satisfied with the required sample size.
The study was approved by the Institutional Review Board of S Hospital (IRB No. 4-2011-
0746) in Seoul, Korea. After the patients voluntarily agreed to participate in the study and
signed the informed consent forms, they completed the questionnaires.
Questionnaires
Demographic & clinical characteristics. Sex, age, education, occupation status, marital
status, and household income were collected for the demographic characteristics, and disease
duration, antiviral therapy, AST/ALT ratio, and family history were collected for the clinical
characteristics.
The revised PFS. The revised PFS consists of 22 numerical items to assess fatigue at the
time of the questionnaire [9]. The items are scored on a 0–10 Likert scale and measure the four
dimensions of behavioral/severity (six items), affective meaning (five items), sensory (five
items), and cognitive/mood (six items). To calculate the subscale score, the scores of the items
on the specific subscales are summed and divided by the number of items in the subscale. All
item scores are summed and divided by 22 to calculate the total fatigue score, which has a
range from 0 to 10, with a high score indicating a high fatigue level.
The investigator got approved from the authors of original instrument and the translation
process of the revised PFS proceeded based on back-and –forth translation method [17, 18] as
follow steps: 1) a bilingual nursing researcher translated from English into Korean. 2) another
bilingual nursing researcher independently back-translated from the Korean version into
English. 3) a doctor and a nurse in division of Gastroenterology confirmed the Korean version
of revised PFS.
The reliability coefficient of the original scale was 0.97 [9], while that of the Korean version
was 0.93 among patients with breast cancer [19].
Statistical analysis
The SPSS/WIN 20 program and STATA 13 were used to analyze the data. A descriptive analy-
sis was performed to determine the demographic characteristics of participants. The distribu-
tion of scores of all items of the PFS was examined by mean, standard deviation, and floor and
ceiling effects. Floor and ceiling effects were examined using the frequency of highest and low-
est scores. Floor and ceiling effects can explain skewness of the data, and the data distribution
can be considered skewed if 15~20% or more of the subjects are grouped at either extreme
[20].
Exploratory factor analysis was conducted to examine the construct validity of the PFS. To
determine the appropriateness of factor analysis, the Kaiser-Meyer-Olkin test and Bartlett’s
test of sphericity were measured for sampling adequacy. Principal component analysis was
used to create factors with direct oblimin rotation. If factor loadings were greater than 0.50,
they were considered statistically significant based on the sample size [21]. The Kaiser criterion
(K1), the cut-off criteria of eigenvalue >1.0, was used to select the number of factors, and the
Minimum Average Partial (MAP) confirmed the result of K1.
Internal consistency reliability of the scale was estimated using Cronbach’s alpha for the
total scale and the factors.
Validation of the revised piper fatigue scale in Koreans with chronic hepatitis B
PLOS ONE | https://doi.org/10.1371/journal.pone.0177690 May 23, 2017 3 / 11
Results
Participant characteristics
Demographic and clinical characteristics of the participants are presented in Table 1. Among
146 participants, two-thirds were men, and the mean age was 48.68±11.81 years. More than
half of the participants came had less than a high school education, 55.5% of participants had
jobs, and the majority were married. The mean monthly income was relatively high. For
clinical characteristics, the disease duration was 15.32±9.46 years, and 71.9% of participants
were taking antiviral drugs. The mean values of the liver function test were within the normal
ranges, and 39% of participants had maternal HBV history. According to the eligibility crite-
ria of the study, the patients who had liver cirrhosis or hepatocellular carcinoma were not
included.
Construct validity. Using 15% as cut-off for floor and ceiling effects [20], no items dem-
onstrated any floor and ceiling effects. Factor analysis was performed to evaluate the construct
Table 1. Demographic & clinical characteristics.
Demographic (N =146) Mean (SD) n (%)
Sex men 88(60.3)
women 58(39.7)
Age 48.68 (11.81)
Education high school 80(54.8)
>high school 66(45.2)
Occupation Employed 81(55.5)
Unemployed 65(44.5)
Marital status Yes 121(82.9)
No 25(17.1)
Monthly household income
(10,000KRW)
431.03(334.39)
Clinical (N =146) Mean (SD) n (%)
Length of diagnosis (Year) 15.32(9.46)
Antiviral therapy Yes 105(71.9)
No 41(28.1)
Laboratory tests
AST (IU/L) 29.52(18.95)
ALT (IU/L) 29.58(25.44)
Total bilirubin (mg/dL) 0.91(0.58)
Alkaline Phosphatase (IU/L) 64.03(30.82)
HBV DNA(copies/mL)  2,000 97(66.4)
> 2,000 47(32.2)
Family historya
Mother Yes 57(39.0)
Father Yes 24(16.4)
Sibling Yes 66(45.2)
Grandmother Yes 3(2.1)
Grandfather Yes 4(2.7)
Others Yes 3(2.1)
AST, aspartate transaminase; ALT, alanin transaminase; HBV, hepatitis B virus; DNA, deoxyribo-nucleic acid
a multiple responses
https://doi.org/10.1371/journal.pone.0177690.t001
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validity. The Kaiser-Meyer-Olkin score was .92, supporting the adequacy of the data for
exploratory factor analysis. In addition, Bartlett’s test of sphericity, a test for overall signifi-
cance of correlations within a matrix, was statistically significant (p<.001), also supporting the
use of factor analysis.
Based on the K1 rule, four factors were extracted and accounted for 75.0% of the variance
(Table 2). The results of MAP confirmed that the scale consists of four factors (Table 3).
Among the four factors, two were the same as in the original behavioral, severity, and
affective meaning subscale, but there were some changes in the other two factors. Three
items of patient/impatient, relaxed/tense, and exhilarated/depressed were moved from the
cognitive/mood subscale to the sensory subscale. Finally, factor I, the sensory subscale,
accounted for 53.5% of the variance, and its number of items increased from 5 to 7 com-
pared with the original PFS. Factor IV, the cognitive and mood subscale, explained 5.4% of
the variance, and its number of items decreased from 6 to 3 compared with the original PFS
(Table 4).
The total PFS severity was moderate, as shown in Table 5. Based on the original scale, the
highest subscale score was 4.67±1.91 for sensory, and the lowest subscale score was 3.96±2.30
for behavioral/severity. After factor analysis, the scores of the sensory subscale and cognitive/
mood subscale were significantly different from the original ones (t = 3.09, p = .002; t = 5.20,
p<.001).
Table 2. Factor loading for total items.
Item Factor I
Sensory
Factor II
Behavioral /Severity
Factor III
Affective meaning
Factor IV
Cognitive
/Mood
2. Distress .167 .778 .044 -.103
3. Interfering with work/school activities .071 .805 .072 -.076
4. Interfering with socializing friend -.051 .790 .107 .082
5. Interfering with sexual activity -.012 .787 -.178 .086
6. Interfering with doing activities you enjoy .019 .825 .056 .053
7. Intensity/severity of fatigue .076 .819 .129 -.066
8. Pleasant/unpleasant .110 .028 .874 -.130
9. Agreeable/disagreeable .109 -.062 .891 -.011
10. Protective/ destructive .020 .067 .646 .318
11. Positive/negative -.056 .119 .801 .204
12. Normal/abnormal -.056 .273 .695 .138
13. Strong/weak .654 .037 .134 -.129
14. Awake/sleepy .772 .136 .001 -.040
15. Lively/listless .767 .074 .005 .150
16. Refreshed/tired .855 .079 -.064 .108
17. Energetic/unenergetic .861 .070 -.087 .041
18. Patient/impatient .548 -.040 .046 .437
19. Relaxed/tense .681 .081 .000 .171
20. Exhilarated/depressed .590 -.093 .352 -.036
21. Ability to concentrate .336 .011 .141 .598
22. Ability to remember .126 .040 .036 .835
23. Ability to think clearly .005 .109 .144 .817
Note. The bold values in the shaded boxes indicate items with highest loading onto each component.
https://doi.org/10.1371/journal.pone.0177690.t002
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Reliability. In this study, Cronbach’s alpha for the total items was 0.96. After the factor
analysis, the Cronbach’s alpha of the sensory subscale increased from 0.91 to 0.93, and that of
the cognitive/mood subscale increased from .90 to .92 (Table 5).
Discussion
This study was conducted to evaluate the construct validity and reliability of the Korean
version of the revised PFS in Koreans with HBV. The results of this study support that the
22-item Korean version of the revised PFS is valid and reliable in this sample. However, some
items were moved to different subscale categories after conducting Kaiser Criterion and MAP
tests.
The number of factors in this sample was almost identical to that in the original version,
and no item was excluded. We conducted Kaiser Criterion (K1 rule) and MAP tests in order
to identify the factors in this study. One of the most difficult steps for performing exploratory
factor analysis is determining how many factors to retain. Several methods such as Bartlett’s
test, K1 rule, Cattell’s scree test, Velicer’s MAP test, and Horn’s parallel analysis have been sug-
gested to determine the number of factors [22]. Among these methods, K1 rule and Cattell’s
scree test have been used in many nursing studies. K1 is a well-known method for selecting the
number of factors, and it is the default option in the SPSS program, although it has been
shown to be the most inaccurate of the methods [23]. Many critics have shown that K1 tends
Table 3. Velicer’s average squared correlations.
Components Average Squared Correlations
0 0.2739
1 0.0527
2 0.0467
3 0.0328
4 0.0261**
5 0.0299
6 0.0337
7 0.0387
8 0.0415
9 0.0481
10 0.0563
11 0.0644
12 0.0755
13 0.0888
14 0.1045
15 0.1263
16 0.1521
17 0.1809
18 0.2218
19 0.3075
20 0.4805
21 1.0000
Note.
**The smallest average squared correlation is 10-2x2.605151966.
The advised number of components based on the smallest minimum average partial is in bold.
https://doi.org/10.1371/journal.pone.0177690.t003
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to overestimate the number of factors [24], and some critics have demonstrated that it some-
times underestimates the number of factors [22]. According to the simulation study for evalu-
ating the accuracy of various methods across 10,000 target data sets, K1 rule showed a low
overall accuracy rate (8.8%) [25]. Cattell’s scree test can also be ambiguous and subjective if
there is no clear break or curve in the chosen eigenvalues [24].
Table 4. Results of exploratory factor analysis.
Item Mean (SD) Floor
(%)
Ceiling
(%)
Factor loading Item to total correlation
Behavioral/Severity
2. Distress 4.49(2.13) 2.1 .7 .778 .699
3. Interfering with work/school activities 4.36(2.56) 2.1 2.1 .805 .670
4. Interfering with socializing friend 3.34(2.39) 5.5 2.7 .790 .681
5. Interfering with sexual activity 3.38(2.69) 13.7 1.4 .787 .498
6. Interfering with doing activities you enjoy 3.81(2.40) 4.8 2.7 .825 .719
7. Intensity/severity of fatigue 4.36(2.31) 8.9 1.4 .819 .740
Affective meaning
8. Pleasant/unpleasant 5.12(2.15) .7 2.7 .874 .645
9. Agreeable/disagreeable 5.08(2.37) 1.4 3.4 .891 .657
10. Protective/ destructive 4.47(2.18) 2.1 1.4 .646 .714
11. Positive/negative 4.27(2.25) .7 .7 .801 .735
12. Normal/abnormal 4.00(2.15) .7 .7 .695 .737
Sensory
13. Strong/weak 4.89(2.30) 1.4 2.7 .654 .575
14. Awake/sleepy 4.53(2.38) 1.4 2.1 .772 .722
15. Lively/listless 4.60(2.29) .7 2.1 .767 .797
16. Refreshed/tired 4.74(2.11) 5.5 1.4 .855 .801
17. Energetic/unenergetic 4.58(2.09) 4.8 .7 .861 .734
18. Patient/impatient 4.10(2.29) .7 1.4 .548 .726
19. Relaxed/tense 4.21(2.16) 1.4 .7 .681 .733
20. Exhilarated/depressed 4.77(2.13) 3.4 1.4 .590 .641
Cognitive/Mood
21. Ability to concentrate 4.08(2.18) .7 .7 .598 .757
22. Ability to remember 3.66(2.08) .7 2.7 .835 .668
23. Ability to think clearly 3.45(2.05) .7 2.1 .817 .686
Total fatigue score 4.29(1.64)
https://doi.org/10.1371/journal.pone.0177690.t004
Table 5. Comparison of subscale values and Cronbach’s alpha between original PFS & changed PFS.
Subscale Original PFS (N =146) Changed PFS (N =146) t p
Number of Items Mean (SD) Cronbach’s alpha Number of Items Mean (SD) Cronbach’s alpha
Behavioral/Severitya 6 3.96(2.30) .92 6 - - - -
Affective meaninga 5 4.59(1.96) .93 5 - - - -
Sensory 5 4.67(1.91) .91 8 4.55(1.80) .93 3.09 .002
Cognitive/Mood 6 4.05(1.76) .90 3 3.73(1.95) .92 5.20 <.001
Total fatigue score 22 4.29(1.64) .96 22
a no change
https://doi.org/10.1371/journal.pone.0177690.t005
Validation of the revised piper fatigue scale in Koreans with chronic hepatitis B
PLOS ONE | https://doi.org/10.1371/journal.pone.0177690 May 23, 2017 7 / 11
Hence, the investigators should consider the alternative statistical methods to compensate
for the weakness of the K1 rule in exploratory factor analysis, although previous studies testing
the construct validity of the revised PFS have not considered the risk of overestimation [19,
26]. The MAP test was suggested as an alternative method and is based on the matrix of partial
correlations [27, 28]. Velicer (1976) explained that the MAP test gives an exact stopping point
and has a direct rationale with consideration for a traditional criterion for factor analysis [27,
28]. Zwick and Velicer (1982) also determined that it was more accurate in identifying a
known number of components than K1 [29]. Therefore, we confirmed the number of factors
with the MAP test in order to reduce the modeling error, and the result of the MAP test did
not differ from that of the K1 rule in this study. Based on the agreement of the two methods,
we finally determined the number of factors of the revised PFS Korean version to be four.
This result indicates the suitability of the revised PFS to measure the nature of fatigue in this
population.
The number of factors was the same as with the original scale, but the items of sensory and
cognitive/mood subscales needed to be rearranged. This result was similar to the results of
prior studies using Swedish, Italian, and French versions of the tool in cancer patients [26, 30,
31]. In the previous studies of Italian cancer patients undergoing chemotherapy and of Swed-
ish cancer patients undergoing curative radiotherapy, the three items of patient/impatient,
relaxed/tense, and exhilarated/depressed were combined into the sensory subscale instead of
cognitive/mood [26, 30]. In the French version, the cognitive/mood subscale was separated
into two subscales for solid cancer patients undergoing treatments [31].
On the other hand, some previous studies have reported different results from the current
study. For example, an Italian study of cancer patients included relaxed/tense in the affective
meaning subscale rather than the sensory subscale [32]. The Dutch version of the revised PFS
for breast and lung cancer patients reported that all items were matched with the items of the
original subscales [33]. In addition, a construct validity study of the revised PFS in Korean
women with breast cancer reported that the three items pleasant/unpleasant, strong/weak, and
exhilarated/depressed were eliminated from the original scale [19]. These disagreements on
the original scale might be due to disease characteristics, cultural characteristics, or language
differences. The investigators should estimate the psychometric properties of this population
because a valid and reliable instrument is an essential component in quantitative research, and
the results analysis depends on the validity of the instrument [34]. Furthermore, the evaluation
of psychometric properties should be performed before using the PFS in other populations or
circumstance, even though the instrument was originally proven to be valid [35, 36]. It is diffi-
cult to be sure of this validity because no study evaluating the psychometric properties of the
revised PFS targeting hepatitis B patients has been conducted, although Korean hepatitis B
patients do not seem to distinguish physical senses from mood, based on the study results.
Overall, sensory and cognitive/mood subscales need to be revaluated in the various cultures
and populations.
We measured Cronbach’s alpha to evaluate reliability after regrouping the items based on
the results of factor analysis. Cronbach’s alpha for the total scale was 0.96 in this study, and this
value is similar to that of the original revised PFS [9], and it is higher than Lee (1999)’s results
of the Korean version of the revised PFS targeting women with breast cancer [19].
There are some limitations to the current study. First, the results of the study cannot be gen-
eralized because this sample was collected in one hospital. Further study should be conducted
with larger and diverse patients with hepatitis B. In addition, the healthy control group was
not included in this study and other fatigue measurements were not used for comparing with
the revised PFS scale. Accordingly, convergent and criterion validity should be confirmed and
test-retest-stability should be assessed in further studies.
Validation of the revised piper fatigue scale in Koreans with chronic hepatitis B
PLOS ONE | https://doi.org/10.1371/journal.pone.0177690 May 23, 2017 8 / 11
Although the revised PFS was developed for cancer patients, it has been translated into vari-
ous languages for diverse populations and has been used to evaluate psychometric properties
in many countries. However, the previous studies have presented the validity and reliability
using a single analysis method such as K1, and there might be limitations to understanding the
characteristics and relations of items in the instruments. This study has significance in that it is
the first to evaluate the validity and reliability of the scale for Korean hepatitis B patients using
multiple methods to explore the psychometric properties of the revised PFS. It can be sug-
gested that various tests need to be conducted to confirm the validity and reliability of the
instrument.
Conclusions
The study demonstrated the psychometric properties of the Korean version of the revised PFS
as tested in patients with chronic hepatitis B. The results of the study revealed that the 22-item
Korean version of the revised PFS is valid and reliable in Koreans with chronic hepatitis B.
Further larger validation studies need to be performed in Korean patients.
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